Recent Articles

• 
  Biopharma

  KRW 100,000 ‘Korean Wegovy’ May Launch This Month

  ?Affordable ‘Korean Wegovy’ to Be LaunchedThe so-called “Korean Wegovy” is expected to be released as early as the end of this month. On the 7th, the Ministry of Food and Drug Safety approved Hanmi Pharmaceutical’s “Efe Autoinjector Injection (Efe),” the first domestically developed glucagon-like pe

  2026.10.08
• 
  Global Business

  Samsung Biologics Speeds Japan, APAC End-to-End CDMO Push

  On 7 October, James Choi, Executive Vice President and Head of Business Support at Samsung Biologics, gives a presentation on Samsung Biologics’ end-to-end contract development and manufacturing organization (CDMO) capabilities at the “BIO JAPAN 2026” seminar held in Yokohama, Japan. Courtesy of Sam

  2026.10.07
• 
  Pharmaceutical R&D

  Are Quantum Computers Useful for Drug Discovery? Korea-France Joint Study

  Provided by Quandela Can photonic quantum computers be practically useful in real-world research settings? A domestic research institute and a French company will jointly verify this in the context of new drug development.French photonic quantum computing company Quandela and the Korea Research Inst

  2026.10.07
• 
  Medical / Research

  Hearing Rehab Tied to Lower Dementia Risk

  The “Hearing Loss Expert Forum” held at Lotte Hotel in Sogong-dong, Seoul on the 1st. Provided by Cochlear Domestic research has found that patients with severe hearing loss who received auditory rehabilitation, such as cochlear implants or hearing aids, had a lower risk of developing dementia than

  2026.10.07
• 
  Clinical Trial

  HK inno.N Obesity Drug Cuts Youth Weight 12.6%

  HK inno.N’s introduced GLP-1 class obesity treatment “Ecnoglutide” reduced body mass index (BMI) by up to 12.6% over 20 weeks in an early-stage clinical trial in adolescents with obesity.HK inno.N announced that its Chinese partner CyNwind Biosciences presented the results of a phase 1b clinical tri

  2026.10.07
• 
  AI Healthcare

  Student-Drug Abuse Spurs Startup; Two Ventures Selected

  경희대학교 student startup team Tabtension (CEO Kim Yoo-chan) has begun developing an auxiliary diagnostic technology that identifies high-risk groups for ADHD using tablet touch data. CEO Kim explained that the startup was motivated by his experience studying in the Daechi-dong private education distric

  2026.10.07
• 
  Medical / Research

  How Hypertension Damages Knees, Worsens Arthritis

  A domestic research team has identified a mechanism by which hypertension can further accelerate the progression of already advanced osteoarthritis. Photo = Getty Images Bank. Osteoarthritis is a representative joint disease that becomes more common with age. According to the World Health Organizati

  2026.10.06
• 
  Biotech

  Kyung Hee, Sogang develop high-performance eco rubber

  From left: Professor Eun-Yeol Lee of Kyung Hee University, Professor Je-Young Park of Sogang University, Kyung Hee University graduate student Rizki Utami, Sogang University graduate student Jiheon Kim, and Kyung Hee University graduate student Tisa Rani Saha. Provided by Kyung Hee University Kyung

  2026.10.06
• 
  Diagnostics / Monitoring

  Can Smart Glasses Help Prevent Dementia?

  Results of gamma-frequency light stimulation under four conditions combining transparent/non-transparent OLED glasses and presence/absence of ambient light. Courtesy of Seoul National University Bundang Hospital A “transparent OLED smart glasses” device has been developed that can stimulate the brai

  2026.10.06
• 
  Biopharma

  Samsung Bioepis, Teva to Co-Develop Two Biosimilars

  Samsung Bioepis is embarking on collaboration with global pharmaceutical company Teva on the development and commercialization of two biosimilar candidates for immune disease treatments.Samsung Bioepis announced on the 1st that it has signed a partnership agreement with Teva Pharmaceutical Industrie

  2026.10.01